These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 24289472)

  • 1. The clinicopathological significance and relationship of Gli1, MDM2 and p53 expression in resectable pancreatic cancer.
    Sheng W; Dong M; Zhou J; Li X; Liu Q; Dong Q; Li F
    Histopathology; 2014 Mar; 64(4):523-35. PubMed ID: 24289472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Correlation between Gli1 expression and clinicopathological significance in human pancreatic cancer].
    Sheng WW; Dong M; Zhou JP; Liu QF; Li X; Dong Q
    Zhonghua Wai Ke Za Zhi; 2013 Oct; 51(10):916-21. PubMed ID: 24433772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of Gli1 in the invasion and migration of pancreatic cancer cells].
    Sheng W; Dong M; Zhou J; Liu Q; Li X; Dong Q
    Zhonghua Wai Ke Za Zhi; 2014 Jul; 52(7):518-22. PubMed ID: 25262609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gli1 expression in pancreatic ductal adenocarcinoma and its clinical significance.
    Abula Y; Yi C; Wang XY; Wang M; Qin RY; Guo YQ; Lin H; Li HJ
    Genet Mol Res; 2015 Oct; 14(4):12323-9. PubMed ID: 26505381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The relationship and clinicopathological significance of Numb,MDM2 and p53 expression in human pancreatic cancer].
    Sheng W; Dong M; Zhou J; Li X; Liu Q; Dong Q; Li F
    Zhonghua Wai Ke Za Zhi; 2014 Sep; 52(9):675-81. PubMed ID: 25410780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cooperation among Numb, MDM2 and p53 in the development and progression of pancreatic cancer.
    Sheng W; Dong M; Zhou J; Li X; Liu Q; Dong Q; Li F
    Cell Tissue Res; 2013 Nov; 354(2):521-32. PubMed ID: 23881403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of calreticulin contributes to the development and progression of pancreatic cancer.
    Sheng W; Chen C; Dong M; Zhou J; Liu Q; Dong Q; Li F
    J Cell Physiol; 2014 Jul; 229(7):887-97. PubMed ID: 24264800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cooperation of Musashi-2, Numb, MDM2, and P53 in drug resistance and malignant biology of pancreatic cancer.
    Sheng W; Dong M; Chen C; Wang Z; Li Y; Wang K; Li Y; Zhou J
    FASEB J; 2017 Jun; 31(6):2429-2438. PubMed ID: 28223335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological correlations of cyclooxygenase-2, MDM2, and p53 expressions in surgically resectable pancreatic invasive ductal adenocarcinoma.
    Hermanova M; Karasek P; Nenutil R; Kyr M; Tomasek J; Baltasova I; Dite P
    Pancreas; 2009 Jul; 38(5):565-71. PubMed ID: 19346994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MDM2 SNP309 associates with accelerated pancreatic adenocarcinoma formation.
    Grochola LF; Müller TH; Bond GL; Taubert H; Udelnow A; Würl P
    Pancreas; 2010 Jan; 39(1):76-80. PubMed ID: 19752772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression and clinical significance of P53 pathway-associated proteins in pancreatic carcinoma].
    Yu GZ; Zhu MH; Chen Y; Ni CR; Li FM
    Ai Zheng; 2005 Nov; 24(11):1398-403. PubMed ID: 16552971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological significance of p53 and mdm2 protein expression in human pancreatic cancer.
    Dong M; Ma G; Tu W; Guo KJ; Tian YL; Dong YT
    World J Gastroenterol; 2005 Apr; 11(14):2162-5. PubMed ID: 15810085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated transcript levels from the MDM2 P1 promoter and low p53 transcript levels are associated with poor prognosis in human pancreatic ductal adenocarcinoma.
    Grochola LF; Taubert H; Greither T; Bhanot U; Udelnow A; Würl P
    Pancreas; 2011 Mar; 40(2):265-70. PubMed ID: 21404460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of proteins in p53 (p14ARF-mdm2-p53-p21WAF/CIP1) pathway and their significance in exocrine pancreatic carcinoma].
    Yu GZ; Zhu MH; Ni CR; Li FM; Zheng JM; Gong ZJ
    Zhonghua Bing Li Xue Za Zhi; 2004 Apr; 33(2):130-4. PubMed ID: 15132849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of TP53 codon 72 and MDM2 SNP 309 polymorphisms in pancreatic ductal adenocarcinoma.
    Hori Y; Miyabe K; Yoshida M; Nakazawa T; Hayashi K; Naitoh I; Shimizu S; Kondo H; Nishi Y; Umemura S; Kato A; Ohara H; Inagaki H; Joh T
    PLoS One; 2015; 10(3):e0118829. PubMed ID: 25734904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Musashi2 promotes the progression of pancreatic cancer through a novel ISYNA1-p21/ZEB-1 pathway.
    Zhou L; Sheng W; Jia C; Shi X; Cao R; Wang G; Lin Y; Zhu F; Dong Q; Dong M
    J Cell Mol Med; 2020 Sep; 24(18):10560-10572. PubMed ID: 32779876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GLI1 facilitates the migration and invasion of pancreatic cancer cells through MUC5AC-mediated attenuation of E-cadherin.
    Inaguma S; Kasai K; Ikeda H
    Oncogene; 2011 Feb; 30(6):714-23. PubMed ID: 20972463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined p53 and MDM2 biomarker analysis shows a unique pattern of expression associated with poor prognosis in patients with renal cell carcinoma undergoing radical nephrectomy.
    Noon AP; Polański R; El-Fert AY; Kalirai H; Shawki H; Campbell F; Dodson A; Eccles RM; Lloyd BH; Sibson DR; Coupland SE; Lake SL; Parsons K; Vlatković N; Boyd MT
    BJU Int; 2012 Apr; 109(8):1250-7. PubMed ID: 21756282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gli1 promotes transforming growth factor-beta1- and epidermal growth factor-induced epithelial to mesenchymal transition in pancreatic cancer cells.
    Liu Q; Sheng W; Dong M; Dong X; Dong Q; Li F
    Surgery; 2015 Jul; 158(1):211-24. PubMed ID: 25979438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia activates the hedgehog signaling pathway in a ligand-independent manner by upregulation of Smo transcription in pancreatic cancer.
    Onishi H; Kai M; Odate S; Iwasaki H; Morifuji Y; Ogino T; Morisaki T; Nakashima Y; Katano M
    Cancer Sci; 2011 Jun; 102(6):1144-50. PubMed ID: 21338440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.